These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20164783)

  • 41. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay.
    Kashif W; Khawaja A; Yaqub S; Hussain SA
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury.
    Duan C; Cao Y; Liu Y; Zhou L; Ping K; Tan MT; Tan N; Chen J; Chen P
    Can J Cardiol; 2017 Jun; 33(6):714-723. PubMed ID: 28392272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
    Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.
    Yin WJ; Yi YH; Guan XF; Zhou LY; Wang JL; Li DY; Zuo XC
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
    Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Duran M
    Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.
    Hami M; Bigdeli A; Khameneh Bagheri R; Rajabi O; Salehi M; Zahedi Avval F
    Iran J Kidney Dis; 2019 Sep; 13(5):304-309. PubMed ID: 31705746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
    Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
    Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
    J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Kocas C; Yildiz A; Abaci O; Karaca OS; Firdin N; Dalgic Y; Bostan C; Ersanli M
    Angiology; 2015 Nov; 66(10):964-8. PubMed ID: 25852211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
    Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
    Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.